 |
 |
|
|
|  PubMed
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
18 June 2002 | Volume 136 Issue 12 | Pages 896-907
Spondyloarthropathies are a cluster of interrelated and overlapping chronic inflammatory rheumatic diseases that primarily include ankylosing spondylitis, reactive arthritis, and the arthritis associated with psoriasis and inflammatory bowel diseases. The primary pathologic sites are the entheses (the sites of bony insertion of ligaments and tendons); the axial skeleton, including the sacroiliac joints; the limb joints; and some nonarticular structures, such as the gut, skin, eye, and aortic valve. Although spondyloarthropathies are not associated with rheumatoid factor, they show a strong association with HLA-B27; however, this association varies markedly among various spondyloarthropathies and among ethnic groups. The most widely used classification criterion, from the European Spondyloarthropathy Study Group, encompasses the currently recognized wider disease spectrum, with a sensitivity and specificity that generally exceed 85%. Spondyloarthropathies occur in genetically predisposed persons and are triggered by environmental factors, but the cellular and molecular mechanisms of inflammation are not yet fully understood. Chlamydial and many enterobacterial infections can trigger reactive arthritis, but an infectious trigger for ankylosing spondylitis has not yet been established. HLA-B27 itself is involved in enhancing genetic susceptibility, but the underlying molecular basis is still unknown; additional genes include the putative susceptibility genes for Crohn disease, ulcerative colitis, and psoriasis. A specific susceptibility gene for Crohn disease, NOD2, is located on chromosome 16q12, and one of the candidate genes for psoriasis, PSORS1, has been mapped to a 60-kb fragment on chromosome 6p, which is telomeric to the HLA-C locus. This paper reviews the efficacy of anti–tumor necrosis factor-
Author and Article Information
From Case Western Reserve University, Cleveland, Ohio.
Grant Support: By an investigator subgrant under National Institutes of Health grant 1 RO1 AR46208-01, CFDA 93.846, UT 201.2.5101.
Requests for Single Reprints: Muhammad Asim Khan, MD, FRCP, Case Western Reserve University, MetroHealth Medical Center, Division of Rheumatology, 2500 MetroHealth Drive, Cleveland, OH 44109. UPDATE
Update on Spondyloarthropathies
therapy and other therapeutic advances.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Facebook 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
 |
|
  D. Elewaut and M. Matucci-Cerinic Treatment of ankylosing spondylitis and extra-articular manifestations in everyday rheumatology practice Rheumatology, June 26, 2009; (2009) kep146v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Boonen, M. van Berkel, I. Kirchberger, A. Cieza, G. Stucki, and D. van der Heijde Aspects relevant for functioning in patients with ankylosing spondylitis according to the health professionals: a Delphi study with the ICF as reference Rheumatology, June 19, 2009; (2009) kep150v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Rojas-Vargas, E. Munoz-Gomariz, A. Escudero, P. Font, P. Zarco, R. Almodovar, J. Gratacos, J. Mulero, X. Juanola, C. Montilla, et al. First signs and symptoms of spondyloarthritis--data from an inception cohort with a disease course of two years or less (REGISPONSER-Early) Rheumatology, April 1, 2009; 48(4): 404 - 409. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. H. Shmerling Testing for Anti-Cyclic Citrullinated Peptide Antibodies: Is It Time to Set This Genie Free? Arch Intern Med, January 12, 2009; 169(1): 9 - 14. [Full Text] [PDF]
|
|
|
|
 |
|
 I H Song, J Carrasco-Fernandez, M Rudwaleit, and J Sieper The diagnostic value of scintigraphy in assessing sacroiliitis in ankylosing spondylitis: a systematic literature research Ann Rheum Dis, November 1, 2008; 67(11): 1535 - 1540. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Armaka, M. Apostolaki, P. Jacques, D. L. Kontoyiannis, D. Elewaut, and G. Kollias Mesenchymal cell targeting by TNF as a common pathogenic principle in chronic inflammatory joint and intestinal diseases J. Exp. Med., February 18, 2008; 205(2): 331 - 337. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K Pathanapitoon, S Suksomboon, P Kunavisarut, S Ausayakhun, S Wattananikorn, N Leetrakool, and A Rothova HLA-B27-associated acute anterior uveitis in the University Referral Centre in North Thailand: clinical presentation and visual prognosis Br. J. Ophthalmol., December 1, 2006; 90(12): 1448 - 1450. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T Sigl, A Cieza, D van der Heijde, and G Stucki ICF based comparison of disease specific instruments measuring physical functional ability in ankylosing spondylitis Ann Rheum Dis, November 1, 2005; 64(11): 1576 - 1581. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Merino, V. Montserrat, A. Paradela, and J. A.L. de Castro Two HLA-B14 Subtypes (B*1402 and B*1403) Differentially Associated with Ankylosing Spondylitis Differ Substantially in Peptide Specificity but Have Limited Peptide and T-cell Epitope Sharing with HLA-B27 J. Biol. Chem., October 28, 2005; 280(43): 35868 - 35880. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. N. Kubiak, R. Moskovich, T. J. Errico, and P. E. Di Cesare Orthopaedic Management of Ankylosing Spondylitis J. Am. Acad. Ortho. Surg., July 1, 2005; 13(4): 267 - 278. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D Laukens, H Peeters, D Marichal, B Vander Cruyssen, H Mielants, D Elewaut, P Demetter, C Cuvelier, M Van Den Berghe, P Rottiers, et al. CARD15 gene polymorphisms in patients with spondyloarthropathies identify a specific phenotype previously related to Crohn's disease Ann Rheum Dis, June 1, 2005; 64(6): 930 - 935. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Butrimiene, S. Jarmalaite, J. Ranceva, A. Venalis, L. Jasiuleviciute, and A. Zvirbliene Different cytokine profiles in patients with chronic and acute reactive arthritis Rheumatology, October 1, 2004; 43(10): 1300 - 1304. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. T. Dawes, J. C. Packham, and J. C. Mucklow TNF therapy for spondyloarthropathy: can we marshal the argument? Rheumatology, September 1, 2004; 43(9): 1069 - 1071. [Full Text] [PDF]
|
|
|
|
|
|
M Rudwaleit, D van der Heijde, M A Khan, J Braun, and J Sieper How to diagnose axial spondyloarthritis early Ann Rheum Dis, May 1, 2004; 63(5): 535 - 543. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Alamanos, N. G. Papadopoulos, P. V. Voulgari, A. Karakatsanis, C. Siozos, and A. A. Drosos Epidemiology of ankylosing spondylitis in Northwest Greece, 1983-2002 Rheumatology, May 1, 2004; 43(5): 615 - 618. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Colmegna, R. Cuchacovich, and L. R. Espinoza HLA-B27-Associated Reactive Arthritis: Pathogenetic and Clinical Considerations Clin. Microbiol. Rev., April 1, 2004; 17(2): 348 - 369. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Hulsmeyer, M. T. Fiorillo, F. Bettosini, R. Sorrentino, W. Saenger, A. Ziegler, and B. Uchanska-Ziegler Dual, HLA-B27 Subtype-dependent Conformation of a Self-peptide J. Exp. Med., January 20, 2004; 199(2): 271 - 281. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. C. Hillig, M. Hulsmeyer, W. Saenger, K. Welfle, R. Misselwitz, H. Welfle, C. Kozerski, A. Volz, B. Uchanska-Ziegler, and A. Ziegler Thermodynamic and Structural Analysis of Peptide- and Allele-dependent Properties of Two HLA-B27 Subtypes Exhibiting Differential Disease Association J. Biol. Chem., January 2, 2004; 279(1): 652 - 663. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T I Temekonidis, Y Alamanos, S N Nikas, D V Bougias, A N Georgiadis, P V Voulgari, and A A Drosos Infliximab therapy in patients with ankylosing spondylitis: an open label 12 month study Ann Rheum Dis, December 1, 2003; 62(12): 1218 - 1220. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. May, M. L. Dorris, N. Satumtira, I. Iqbal, M. I. Rehman, E. Lightfoot, and J. D. Taurog CD8{alpha}{beta} T Cells Are Not Essential to the Pathogenesis of Arthritis or Colitis in HLA-B27 Transgenic Rats J. Immunol., January 15, 2003; 170(2): 1099 - 1105. [Abstract] [Full Text] [PDF]
|
|
